|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| C07K 16/28 | |||
| C07K 16/18 | |||
| A61K 51/10 |
| (11) | Number of the document | 2015775 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07724950.6 |
| Date of filing the European patent application | 2007-04-26 | |
| (97) | Date of publication of the European application | 2009-01-21 |
| (45) | Date of publication and mention of the grant of the patent | 2011-06-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2007/004026 |
| Date | 2007-04-26 |
| (87) | Number | WO 2007/128557 |
| Date | 2007-11-15 |
| (30) | Number | Date | Country code |
| 06090067 | 2006-05-03 | EP | |
| 800011 P | 2006-05-15 | US |
| (72) |
SIEGER, Stephanie, DE
BERNDORFF, Dietmar, DE
DINKELBORG, Ludger, DE
TIJINK, Bernhard, Marcel, NL
VAN DONGEN, Augustinus, Antonius, Maria, Silvester, NL
|
| (73) |
Vereniging VU-Windesheim,
Kamer 3 E-15 De Boelelaan 1105, 1081 HV Amsterdam,
NL
Bayer Pharma Aktiengesellschaft, Müllerstrasse 178, 13353 Berlin, DE |
| (54) | COMBINATION OF AN ANTI EDB FIBRONECTIN DOMAIN ANTIBODY L19-SIP AND AN ANTI-EGFR ANTIBODY |
| COMBINATION OF AN ANTI EDB FIBRONECTIN DOMAIN ANTIBODY L19-SIP AND AN ANTI-EGFR ANTIBODY |